Effect of [6]-Gingerol on viral neuraminidase and hemagglutinin-specific T cell immunity in severe influenza

[1]  Hoyoung Lee,et al.  Dried Ginger Extract Restores the T Helper Type 1/T Helper Type 2 Balance and Antibody Production in Cyclophosphamide-Induced Immunocompromised Mice after Flu Vaccination , 2022, Nutrients.

[2]  Yu-Chia Hsieh,et al.  Role of Pneumococcal NanC in the Severe Disease of Streptococcus pneumoniae Superinfection with Influenza , 2021, ImmunoHorizons.

[3]  R. T. Sasmono,et al.  [6]-Gingerol Inhibits Chikungunya Virus Infection by Suppressing Viral Replication , 2021, BioMed research international.

[4]  E. Sadeghi,et al.  Effect of ginger (Zingiber officinale) supplementation on oxidative stress parameters: A systematic review and meta-analysis. , 2021, Journal of food biochemistry.

[5]  Yu-hua Jia,et al.  6-Gingerol ameliorates sepsis-induced liver injury through the Nrf2 pathway. , 2020, International immunopharmacology.

[6]  S. Shih,et al.  Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[7]  H. Corke,et al.  Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe) , 2019, Foods.

[8]  M. T. Islam,et al.  Protective and therapeutic potential of ginger (Zingiber officinale) extract and [6]‐gingerol in cancer: A comprehensive review , 2018, Phytotherapy research : PTR.

[9]  Dayan Wang,et al.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016 , 2017, Antiviral research.

[10]  M. Nawaz,et al.  Anti-avian influenza virus H9N2 activity of aqueous extracts of Zingiber officinalis (Ginger) and Allium sativum (Garlic) in chick embryos. , 2017, Pakistan journal of pharmaceutical sciences.

[11]  Tse-Ching Chen,et al.  Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model , 2017, Scientific Reports.

[12]  A. Hurt,et al.  Influenza antivirals currently in late‐phase clinical trial , 2017, Influenza and other respiratory viruses.

[13]  D. Smee,et al.  Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice. , 2016, Antiviral research.

[14]  H. Kelly,et al.  Emerging Blockininfectious Blockindiseases Blockin@bullet Blockin Debate regarding Oseltamivir Use for Seasonal and Pandemic Influenza , 2022 .

[15]  Tse-Ching Chen,et al.  Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs , 2016, Scientific Reports.

[16]  Ha T. Nguyen,et al.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015 , 2014, Antiviral research.

[17]  N. Veljkovic,et al.  Natural Products as Promising Therapeutics for Treatment of Influenza Disease. , 2015, Current pharmaceutical design.

[18]  S. Choi,et al.  Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza , 2015, Journal of medical virology.

[19]  S. Bauer,et al.  High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients , 2015, Intensive Care Medicine.

[20]  C. Chiu,et al.  IL-10 inhibits neuraminidase-activated TGF-β and facilitates Th1 phenotype during early phase of infection , 2015, Nature Communications.

[21]  Dayan Wang,et al.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014 , 2015, Antiviral research.

[22]  J. Liao,et al.  Antiviral activity of aloe-emodin against influenza A virus via galectin-3 up-regulation. , 2014, European journal of pharmacology.

[23]  D. Smee,et al.  Favipiravir (T-705), a novel viral RNA polymerase inhibitor. , 2013, Antiviral research.

[24]  M. Peiris,et al.  Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance , 2013, The Lancet.

[25]  Tse-Ching Chen,et al.  Altered T-bet Dominance in IFN-γ–Decoupled CD4+ T Cells with Attenuated Cytokine Storm and Preserved Memory in Influenza , 2013, The Journal of Immunology.

[26]  W. D. Winters,et al.  Toxicologic Assessment of a Commercial Decolorized Whole Leaf Aloe Vera Juice, Lily of the Desert Filtered Whole Leaf Juice with Aloesorb , 2013, Journal of toxicology.

[27]  Samir Samman,et al.  Evaluation of the Nutritional and Metabolic Effects of Aloe vera , 2011 .

[28]  Bin Wang,et al.  Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia , 2010, Emerging infectious diseases.

[29]  M. Eichelberger,et al.  Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  R. Saito,et al.  Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[31]  Fang Fang,et al.  Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein , 2009, PloS one.

[32]  A. Ciucci,et al.  Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational Level* , 2009, The Journal of Biological Chemistry.

[33]  David Smith,et al.  Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. , 2009, Antiviral research.

[34]  Alan L Harvey,et al.  Natural products in drug discovery. , 2008, Drug discovery today.

[35]  H. Ochiai,et al.  Macrophage-mediated inhibitory effect of Zingiber officinale Rosc, a traditional oriental herbal medicine, on the growth of influenza A/Aichi/2/68 virus. , 2006, The American journal of Chinese medicine.

[36]  U. V. von Andrian,et al.  CD4 Effector T Cell Subsets in the Response to Influenza , 2002, The Journal of experimental medicine.

[37]  S. Szabo,et al.  T-bet regulates IgG class switching and pathogenic autoantibody production , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Nagasawa,et al.  Effects of bitter melon (Momordica charantia l.) or ginger rhizome (Zingiber offifinale rosc) on spontaneous mammary tumorigenesis in SHN mice. , 2002, The American journal of Chinese medicine.

[39]  J M Lee,et al.  Chemoprotective properties of some pungent ingredients present in red pepper and ginger. , 1998, Mutation research.

[40]  P. Doherty,et al.  CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. , 1997, Journal of immunology.

[41]  Takuji Tanaka,et al.  Modifying Effects of Fungal and Herb Metabolites on Azoxymethane‐induced Intestinal Carcinogenesis in Rats , 1992, Japanese journal of cancer research : Gann.

[42]  R. Sydiskis,et al.  Inactivation of enveloped viruses by anthraquinones extracted from plants , 1991, Antimicrobial Agents and Chemotherapy.